All public logs

Combined display of all available logs of Beacon. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

16:53, 6 December 2023 Francine talk contribs created page Compilation: ESMO Guidelines (European Union - wide Resources) (Created page with "Go back to European Union - wide Resources page {{forproviders}} '''Sponsor, manager or home institution:''' European Society for Medical Oncology '''Primary purpose:''' Give providers recommendations prepared and reviewed by leading experts in each topic to help patients with the best care available. '''Available guidelines:''' Available Guidelines: ESMO Guidelines '''Type of information:''' Guidelines for each step in the cancer journey including informatio...")
19:00, 5 December 2023 Francine talk contribs created page Trials (Rijnstate) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Rijnstate page '''NCTID''': NCT00091156 '''Title''': Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer '''Study Summary''': RATIONALE: Gefitinib may stop the growth of tumor cells by blocking the enzymes necessary for their growth. It is not yet known whether giving gefitinib after initial chemotherapy is effective in delaying the recurrence of n...")
18:55, 5 December 2023 Francine talk contribs created page Trials (Radboudumc Centre for Oncology) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Radboudumc Centre for Oncology page '''NCTID''': NCT01322490 '''Title''': A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer '''Study Summary''': The purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall surv...")
18:46, 5 December 2023 Francine talk contribs created page Course: Eduplaza: online education catalogue (Erasmus MC Kanker Instituut) (Created page with "{{forresearchers}} {{forproviders}} Go back to Erasmus MC Kanker Instituut page '''Primary purpose:''' To provide a comprehensive online education catalog (Eduweb) that offers a wide range of e-learning modules and training courses from various education providers associated with Erasmus MC, allowing users to easily search, access, and obtain information about specific offerings. '''Target audience:''' A(N)IOS / doctor or (medical) specialist, Supervisor or (care)...")
18:34, 5 December 2023 Francine talk contribs created page Trials (Erasmus MC Kanker Instituut) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Erasmus MC Kanker Instituut page '''NCTID''': NCT05208047 '''Title''': (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors '''Study Summary''': This is a Phase 3, open-label, international, multicenter study of CGT9486 in combination with sunitinib. This is a multi-part study that will enroll approximately 426 patients. Part 1 consist...")
18:25, 5 December 2023 Francine talk contribs created page Trials (University Medical Center Groningen Comprehensive Cancer Center) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to University Medical Center Groningen Comprehensive Cancer Center page '''NCTID''': NCT03719690 '''Title''': Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy '''Study Summary''': An international, multicenter, open-label, 2 cohort, non-comparative, pivotal study evaluating the efficacy of tipifarnib in HRAS mutant HNSCC (AIM-HN). Th...")
18:17, 5 December 2023 Francine talk contribs created page Trials (The Maastricht UMC+ Comprehensive Cancer Center) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to The Maastricht UMC+ Comprehensive Cancer Center page '''NCTID''': NCT02968303 '''Title''': Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy '''Study Summary''': Rationale: The combination of ipilimumab and nivolumab induces relatively high response rates and promising response depth in late stage melanoma. Nevertheless, it takes time till responses occu...")
18:09, 5 December 2023 Francine talk contribs created page Trials (Netherlands Cancer Institute - Antoni van Leeuwenhoek) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Netherlands Cancer Institute - Antoni van Leeuwenhoek page '''NCTID''': NCT04614103 '''Title''': Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer '''Study Summary''': This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer '''Sponsor''': Iovance Biotherapeutics, Inc....")
17:56, 5 December 2023 Francine talk contribs created page Trials (Uppsala University Hospital) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Uppsala University Hospital page '''NCTID''': NCT00036556 '''Title''': Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer '''Study Summary''': This study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer. '''Sponsor''': Abbott '''Intervention''': Atrasentan '''Start Date''': 2001-06 '''...")
17:50, 5 December 2023 Francine talk contribs created page Trials (Sahlgrenska University Hospital) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Sahlgrenska University Hospital page '''NCTID''': NCT03685890 '''Title''': Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion '''Study Summary''': To evaluate safety and the effect of isolated limb perfusion together with nivolumab as a way to increase efficacy and give further insights in early immunological mechanisms. In the first phase...")
17:41, 5 December 2023 Francine talk contribs created page Trials (Skåne University Hospital Cancer Centre) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Skåne University Hospital Cancer Centre page '''NCTID''': NCT02730416 '''Title''': Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer '''Study Summary''': This study will evaluate the role of addition of an anti-angiogenic agent (Nintedanib/placebo) to conventional combination chemotherapy as concomitant and maintenance treatment in primary advanced or with first relapse of end...")
17:35, 5 December 2023 Francine talk contribs created page Trials (Karolinska Institute and University Hospital) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Karolinska Institute and University Hospital page '''NCTID''': NCT01360554 '''Title''': ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer '''Study Summary''': This is a multinational, multicenter, randomized,double-blinded, Phase 3 study comparing the efficacy and safety of treatment with PF-00299804 to treatment with erlotinib in...")
17:04, 5 December 2023 Francine talk contribs created page Trials (Catalan Institute of Oncology) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Catalan Institute of Oncology page '''NCTID''': NCT02831959 '''Title''': Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). '''Study Summary''': The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NS...")
16:33, 5 December 2023 Francine talk contribs created page Trials (Vall d’Hebron Barcelona Hospital Campus) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Vall d’Hebron Barcelona Hospital Campus page '''NCTID''': NCT00036556 '''Title''': Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer '''Study Summary''': This study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer. '''Sponsor''': Abbott '''Intervention''': Atrasentan '''Start Date''':...")
16:25, 5 December 2023 Francine talk contribs created page Trials (Fundación Instituto Valenciano de Oncología IVO) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Fundación Instituto Valenciano de Oncología IVO page '''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, an...")
16:04, 5 December 2023 Francine talk contribs created page Trials (Institute of Oncology Ljubljana) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Institute of Oncology Ljubljana page '''NCTID''': NCT06060990 '''Title''': Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers '''Study Summary''': The aim of the study is to determine the total concentration of selected trace elements (Cu, Zn, Fe), the proportion of free Cu and Cu bound to ceruloplasmin and the isotopic ratio of Cu65/Cu63 in blo...")
14:28, 5 December 2023 Francine talk contribs created page Trials (The “Prof. Dr. Ion Chiricuta” Institute of Oncology (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to The “Prof. Dr. Ion Chiricuta” Institute of Oncology page '''NCTID''': NCT06112314 '''Title''': IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) '''Study Summary''': This is a phase 3, randomized, controlled study of IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated ad...")
14:20, 5 December 2023 Francine talk contribs created page Trials (Instituto Português de Oncologia de Coimbra Francisco Gentil) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Instituto Português de Oncologia de Coimbra Francisco Gentil page '''NCTID''': NCT04459715 '''Title''': A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) '''Study Summary'''...")
14:16, 5 December 2023 Francine talk contribs created page Trials (Instituto Português de Oncologia de Lisboa Francisco Gentil) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Instituto Português de Oncologia de Lisboa Francisco Gentil page '''NCTID''': NCT04410445 '''Title''': Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence '''Study Summary''': The main purpose of this study is to compare the efficacy of bempegaldesleukin plus nivolumab versu...")
13:04, 5 December 2023 Francine talk contribs created page Trials (Instituto Português de Oncologia do Porto Francisco Gentil) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Instituto Português de Oncologia do Porto Francisco Gentil page '''NCTID''': NCT02500043 '''Title''': Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer '''Study Summary''': The purpose of this trial is to compare the effects of TAS-102 and best supportive care (BSC) with Placebo (an inactive drug) and best supportive care on metastatic gastric cancer. '''Sponsor''': T...")
12:52, 5 December 2023 Francine talk contribs created page Trials (Greater Poland Cancer Centre) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Greater Poland Cancer Centre page '''NCTID''': NCT02467907 '''Title''': Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer '''Study Summary''': This study is to assess safety as defined by the frequency and severity of gastrointestinal (GI) perforation/fistula, GI-vaginal fistula and genitourinary (GU) fistula in p...")
19:15, 4 December 2023 Francine talk contribs created page Trials (National Cancer Institute) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to National Cancer Institute page '''NCTID''': NCT03425643 '''Title''': Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) '''Study Summary''': This trial will evaluate the safety and efficacy of pembrolizumab (M...")
18:58, 4 December 2023 Francine talk contribs created page Trials (Riga Eastern Clinical University Hospital) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Riga Eastern Clinical University Hospital page '''NCTID''': NCT01903733 '''Title''': Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 '''Study Summary''': The objective of the study is to provide long term access to bosutinib treatment and assess long term safety, tolerability and durat...")
18:37, 4 December 2023 Francine talk contribs created page Trials (Fondazione I.R.C.C.S. Policlinico San Matteo) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Fondazione I.R.C.C.S. Policlinico San Matteo page '''NCTID''': NCT05210790 '''Title''': A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera '''Study Summary''': The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV. '''Sponsor''': Protagonist Therapeutics, Inc. '''...")
18:20, 4 December 2023 Francine talk contribs created page Trials (Istituto Nazionale Tumori Regina Elena & Istituto Dermatologico San Gallicano) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Istituto Nazionale Tumori Regina Elena & Istituto Dermatologico San Gallicano page '''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout...")
18:13, 4 December 2023 Francine talk contribs created page Trials (Fondazione Policlinico Universitario Agostino Gemelli IRCCS) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Fondazione Policlinico Universitario Agostino Gemelli IRCCS page '''NCTID''': NCT05323656 '''Title''': A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN) '''Study Summary''': The primary objective of this study is to compare the change in tumour size per Response Evaluation Criteria in Solid Tumours Version...")
18:05, 4 December 2023 Francine talk contribs created page Trials (IRCCS - Romagna Institute for the Study of Cancer Dino Amadori) (Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to IRCCS - Romagna Institute for the Study of Cancer 'Dino Amadori' '''NCTID''': NCT04775290 '''Title''': Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy '''Study Summary''': The study aims to investigate, through serial measurements of some biomarkers, the potential mechanisms through which yoga impacts on QOL and fatigue. '''Sponsor''':...")
17:55, 4 December 2023 Francine talk contribs created page Trials (Sacro Cuore - Don Calabria Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Sacro Cuore - Don Calabria Hospital page '''NCTID''': NCT01940497 '''Title''': A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer '''Study Summary''': This non-randomized, multicenter, open-label study will assess the safety and efficacy of subcutaneously ad...")
17:50, 4 December 2023 Francine talk contribs created page Trials (Mediterranean Institute of Oncology) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Mediterranean Institute of Oncology '''NCTID''': NCT06008691 '''Title''': A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice '''Study Summary''': This is a prospective, observational cohort study to evaluate the clinical impact of novel Monoclonal AntiBodies (MAB) in B-cell Non-Hodgkin Lymphoma (N...")
17:15, 4 December 2023 Francine talk contribs created page Trials (Candiolo Cancer Institute) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Candiolo Cancer Institute page '''NCTID''': NCT04296890 '''Title''': A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression '''Study Summary''': This study is designed to evaluate the efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with platinum-res...")
17:09, 4 December 2023 Francine talk contribs created page Trials (Ospedale San Raffaele) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Ospedale San Raffaele page '''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard...")
17:04, 4 December 2023 Francine talk contribs created page Trials (IRCCS Centro di Riferimento Oncologico della Basilicata) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to IRCCS Centro di Riferimento Oncologico della Basilicata page '''NCTID''': NCT03268954 '''Title''': Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) '''Study Summary''': The purpose of this study is to determine...")
16:59, 4 December 2023 Francine talk contribs created page Trials (Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico page '''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis t...")
16:43, 4 December 2023 Francine talk contribs created page Trials (Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS Istituto in Tecnologie Avanzate e Modelli Assistenziali in Oncologia) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS Istituto in Tecnologie Avanzate e Modelli Assistenziali in Oncologia page '''NCTID''': NCT05929222 '''Title''': Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi '''Study Summary''': Prospective, multicenter, open label, phase III r...")
16:38, 4 December 2023 Francine talk contribs created page Trials (Istituto Nazionale Tumori -IRCCS Fondazione G.Pascale) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Istituto Nazionale Tumori -IRCCS 'Fondazione G.Pascale' page '''NCTID''': NCT03771456 '''Title''': Anastomotic Leakage and Enhanced Recovery Pathways After Colorectal Surgery '''Study Summary''': Prospective observational multicenter study on the influence of adherence to enhanced recovery pathways on early outcomes (anastomotic leakage, morbidity, mortality, readmission, reoperation rates and length...")
16:29, 4 December 2023 Francine talk contribs created page Trials (Humanitas Research Hospital) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Humanitas Research Hospital page '''NCTID''': NCT04800497 '''Title''': The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC '''Study Summary''': Hepatocellular carcinoma (HCC) recurs in up to 60% of patients who undergo resection. Circulating tumor cells (CTC) have been advocated as promotors of the recurrence. However, their role as prognostic markers in the surgic...")
16:22, 4 December 2023 Francine talk contribs created page Trials (Istituto Oncologico Veneto IRCCS-IOV) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Istituto Oncologico Veneto IRCCS-IOV page '''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation...")
16:13, 4 December 2023 Francine talk contribs created page Trials (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano page '''NCTID''': NCT05594290 '''Title''': Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery '''Study Summary''': This is a window-of-opportunity study for patients with resectable Merkel Cell Carcinoma. The aim of this study is to test the activity of a course of chemo-immunotherapy followed by surgery in...")
16:06, 4 December 2023 Francine talk contribs created page Trials (European Institute of Oncology) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to European Institute of Oncology page '''NCTID''': NCT05554003 '''Title''': Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study '''Study Summary''': Study design and rationale: Neuroendocrine neoplasms (NENs ) represent a heterogeneous group of malignancies, which differ in terms of behavio r and prognosis. M...")
15:56, 4 December 2023 Francine talk contribs created page Trials (IRCCS Ospedale Policlinico San Martino) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to IRCCS Ospedale Policlinico San Martino page '''NCTID''': NCT05291156 '''Title''': CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy '''Study Summary''': This is a non-profit phase II, randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy, compared to cetuximab alone, in pre-treated RAS/BRAF wild type met...")
15:45, 4 December 2023 Francine talk contribs created page Trials (Centro di Riferimento Oncologico di Aviano) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Centro di Riferimento Oncologico di Aviano page '''NCTID''': NCT00002903 '''Title''': Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer '''Study Summary''': RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients with recurren...")
15:34, 4 December 2023 Francine talk contribs created page Trials (Saolta University Cancer Network Galway University Hospitals) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Saolta University Cancer Network Galway University Hospitals page '''NCTID''': NCT01176487 '''Title''': Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34 '''Study Summary''': RATIONALE: 3-dimensional conformal radiation therapy may lessen side effects caused by palliative radiation therapy and improve the quality of life...")
15:27, 4 December 2023 Francine talk contribs created page Trials (Trinity St. James Cancer Institute) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Trinity St. James’s Cancer Institute page '''NCTID''': NCT05947903 '''Title''': Validation of the European Oncology Quality of Life Toolkit '''Study Summary''': The improvement or preservation of quality of life (QoL) is one of the three pillars of the European Union (EU) Mission on Cancer, which underpins the needs of patients from cancer diagnosis throughout treatment, survivorship, and advanced...")
14:08, 4 December 2023 Francine talk contribs created page Trials (National Institute of Oncology) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to National Institute of Oncology page '''NCTID''': NCT05169567 '''Title''': Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer '''Study Summary''': This study will evaluate the effect of adding abemaciclib to fulvestrant for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast ca...")
13:27, 4 December 2023 Francine talk contribs created page Resource: Pastoral Care (University Cancer Center Frankfurt) (Created page with "{{forpatients}} Go back to University Cancer Center Frankfurt page '''Primary purpose:''' To provide clinical pastoral care with an open and ecumenical approach, respecting all religions and beliefs, and offering support to all patients, including connecting them with their respective religious communities if desired. '''Access Information:''' Information [https://www.uct-frankfurt.de/fuer-patienten/unterstuetzende-angebote/seelsorge/universitaetsklinikum.html].")
13:23, 4 December 2023 Francine talk contribs created page Resource: Art Therapy (University Cancer Center Frankfurt) (Created page with "{{forpatients}} Go bak to University Cancer Center Frankfurt page '''Primary purpose:''' To offer art therapy for patients in the hospital to help them cope with illness, reduce stress, and express themselves creatively. '''Access Information:''' Information [https://www.uct-frankfurt.de/kunsttherapie/universitaetsklinikum.html].")
13:21, 4 December 2023 Francine talk contribs created page Resource: Sports and Exercise Therapy (University Cancer Center Frankfurt) (Created page with "{{forpatients}} Go back to University Cancer Center Frankfurt page '''Primary purpose:''' Promote physical activity's benefits for cancer patients, offering free courses at all stages of the disease and therapy. '''Access Information:''' Information [https://www.uct-frankfurt.de/sporttherapie/universitaetsklinikum.html].")
13:19, 4 December 2023 Francine talk contribs created page Self-help Groups List (University Cancer Center Frankfurt) (Created page with "{{forpatients}} Go back to University Cancer Center Frankfurt page '''Primary purpose''': The website provides a list of the active self-help groups in the hospital. '''Access Information''': Information [https://www.uct-frankfurt.de/selbsthilfe.html].")
13:17, 4 December 2023 Francine talk contribs created page Novel Therapies and Diagnostic Methods (University Cancer Center Frankfurt) (Created page with "{{forpatients}} Go back to University Cancer Center Frankfurt page === Diagnostics === {| class="wikitable" ! Radiology !! !! !! |- | '''Type''' || '''Name''' || '''Availibility''' || '''Uses per year''' |- | Machine || CT scanners || Yes || |- | Machine || MRI (specify the strength and field of the techniques) || Yes || |- | Machine || Mammography (please specify analogic mammography or digital) || Yes (digital) || |- | Machine || Ultrasound || Yes || |- |...")
13:16, 4 December 2023 Francine talk contribs created page Events: UCT Events (University Cancer Center Frankfurt) (Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Center Frankfurt page '''Primary purpose:''' To provide information about various types of cancer, and their associated symptoms, and to facilitate connections with self-help groups and UCT partners for patients, relatives, and interested individuals. '''Target audience:''' Patients, relatives and the general public. '''Access Information:''' Information [https://www.uct-frankfurt.de/...")